83 Results for "

Drug design

" in MedChemExpress (MCE) Product Catalog:
Products (83)

83 Results for "Drug design" in MCE Product Catalog:

Cat. No.: HY-P4073
CAS No.: 1075214-55-9
Synonyms: GRN1005; Paclitaxel trevatide
Research Areas:  

Cancer

ANG1005 (Paclitaxel trevatide) is a brain-penetrating peptide-drug conjugate. ANG1005, a taxane derivative, consists of three paclitaxel (HY-B0015) molecules covalently linked to Angiopep-2, designed to cross the blood-brain and blood-cerebrospinal barriers and to penetrate malignant cells via low density lipoprotein receptor-related protein (LRP1) transport system .
loading...
    loading...
Cat. No.: HY-P10033
CAS No.: 245080-24-4
Target:  

Ser/Thr Protease

Research Areas:  

Others

SFTI-1 is a cyclic peptide trypsin inhibitor consisting of 14 amino acid residues. SFTI-1 belongs to the Bowman-Birk class of inhibitors. Characterized by its small size, high stability, and potent activity, SFTI-1 can be used for research on peptide drug design platforms .
loading...
    loading...
Cat. No.: HY-W011426
CAS No.: 142-91-6
Synonyms: Propan-2-yl hexadecanoate
Isopropyl palmitate is an fatty acid ester. Isopropyl palmitate can be used for design and characterization of bioactive bilayer films. The bilayer membrane not only has the ability to scavenge free radicals and inhibit lipid peroxidation, but also can inhibit the growth of known foodborne pathogens. Isopropyl palmitate can be used as an excipient, such as lubricant, oily carrier, solvent, controlled-release transdermal film. Pharmaceutical excipients, or pharmaceutical auxiliaries, refer to other chemical substances used in the pharmaceutical process other than pharmaceutical ingredients. Pharmaceutical excipients generally refer to inactive ingredients in pharmaceutical preparations, which can improve the stability, solubility and processability of pharmaceutical preparations. Pharmaceutical excipients also affect the absorption, distribution, metabolism, and elimination (ADME) processes of co-administered drugs .
loading...
    loading...
Cat. No.: HY-Y0135
CAS No.: 532-24-1
Target:  

Drug Intermediate

Research Areas:  

Cancer

Tropinone is an organic synthesis intermediate and a skeleton for constructing derivatives containing thiazole rings and other structures. Tropinone derivatives have anticancer activities such as inducing tumor cell apoptosis and inhibiting tyrosinase activity, and can be used in research such as anticancer drug development and tyrosinase inhibitor design .
loading...
    loading...
Cat. No.: HY-178238
CAS No.: 3040077-52-6
Research Areas:  

Cancer

LD2-3 is a cytotoxic compound derived from Exatecan (HY-13631), designed to be conjugated with anti-FGFR2b or anti-CEA antibodies to form intact antibody-drug conjugate (ADC) molecules. LD2-3 exhibits a remarkable bystander killing effect: it not only effectively kills FGFR2b-positive tumor cells, but also eliminates surrounding FGFR2b-negative cells in co-culture and mixed tumor xenograft models, thereby inducing complete tumor regression. LD2-3 can be used for anti-tumor research in relevant fields such as gastric cancer and lung cancer .
loading...
    loading...
Cat. No.: HY-W004440
CAS No.: 6531-38-0
Research Areas:  

Others

2,2'-(Piperazine-1,4-diyl)diethanamine is a piperazine with two N-ethanamine groups. This type of molecule may be used to build drug molecules or design novel ionizable aminolipid head groups for lipid nanoparticles.
loading...
    loading...
Cat. No.: HY-128871
CAS No.: 2130869-17-7
Research Areas:  

Cancer

VCP-Eribulin is a bioactive molecule-linker conjugate designed for ADCs (Drug-Linker Conjugates for ADC), formed by conjugating an ADC linker (VCP) with Eribulin (HY-13442). Eribulin is a unique microtubule inhibitor exhibiting antitumor activity. VCP-Eribulin can be utilized for antibody conjugation .
loading...
    loading...
Cat. No.: HY-151748
CAS No.: 1994267-98-9
Target:  

ADC Linkers

Research Areas:  

Others

N3-L-Orn(Fmoc)-OH is a non-natural amino acid building block specially designed for solid-phase peptide synthesis and click chemistry. N3-L-Orn(Fmoc)-OH can be used as a linker for ADC (antibody-drug conjugate) or for the development of targeting peptides.
loading...
    loading...
Cat. No.: HY-151661
CAS No.: 1217462-63-9
Purity:  99.15%
Synonyms: L-azidovaline CHA
Target:  

ADC Linkers

Research Areas:  

Others

N3-L-Val-OH (L-azidovaline) (CHA) is a mixture of N3-L-Val-OH and Cyclohexanamine. N3-L-Val-OH is a non-natural amino acid building block specifically designed for solid-phase peptide synthesis and click chemistry. N3-L-Orn(Fmoc)-OH can be used as a linker for ADC (antibody-drug conjugate) or for the development of targeting peptides.
loading...
    loading...
Cat. No.: HY-164785
CAS No.: 2748951-17-7
Target:  

Drug Intermediate

Research Areas:  

Others

TCO-PEG5-maleimide is a PEG linker with TCO and maleimide groups, specifically enabling tetrazine click chemistry and thiol conjugation for bioconjugation, probe design, and drug delivery.
loading...
    loading...
Cat. No.: HY-151736
CAS No.: 1932432-15-9
Target:  

ADC Linkers

Research Areas:  

Others

N3-L-Dap(Boc)-OH is a non-natural amino acid building block specially designed for solid-phase peptide synthesis and click chemistry. N3-L-Dap(Boc)-OH can be used as a linker for ADC (antibody-drug conjugate) or for the development of targeting peptides.
loading...
    loading...
Cat. No.: HY-151843
CAS No.: 473430-12-5
Target:  

ADC Linkers

Research Areas:  

Others

N3-L-Lys(Fmoc)-OH is a non-natural amino acid building block specially designed for solid-phase peptide synthesis and click chemistry. N3-L-Lys(Fmoc)-OH can be used as a linker for ADC (antibody-drug conjugate) or for the development of targeting peptides.
loading...
    loading...
Cat. No.: HY-16387
CAS No.: 854514-88-8
Target:  

VEGFR

Research Areas:  

Others

PF-00337210 is a potent and selective inhibitor of VEGFRs, designed for treating age-related macular degeneration via intravitreal injection. The formulation strategy focused on developing an ophthalmic solution that would precipitate upon injection into the vitreous, ensuring sustained drug delivery. Challenges included maintaining low dosing volumes, selecting safe excipients for intravitreal use, and addressing the drug's unique physicochemical properties. The final formulation, an isotonic solution in a citrate-buffered vehicle with NaCl, demonstrated stability, potency, and recovery through intravitreal dosing syringes. It formed a depot upon injection into vitreous humor, representing a novel nonpolymeric in situ-forming depot formulation for intravitreal drug delivery .
loading...
    loading...
Cat. No.: HY-W010778
CAS No.: 231278-20-9
Target:  

Drug Derivative

Research Areas:  

Others

N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-iodo-quinazolin-4-amine is a quinazoline derivative that has also been used in the design, synthesis and biological evaluation of quinazoline-phosphoramidate mustard conjugates as anticancer drugs.
loading...
    loading...
Cat. No.: HY-P10417
CAS No.: 222557-93-9
Target:  

Integrin IFNAR

Research Areas:  

Cancer

RTDLDSLRTYTL is an Alpha (v) beta (6) integrin (avb6) inhibitor with high affinity and specificity. RTDLDSLRTYTL binds to avb6 integrin, a peptide sequence that activates cytotoxicity and cytokine production in T cells, such as interferon-gamma. RTDLDSLRTYTL is designed through a chimeric T cell antigen receptor (CAR) so that T cells can be redirected to specifically recognize and attack tumor cells. RTDLDSLRTYTL can be used in the research of cancer immunotherapy and targeted drug development .
loading...
    loading...
Cat. No.: HY-160985
CAS No.: 88041-40-1
Target:  

Parasite

Research Areas:  

Others

Lemidosul is an anti-trypanosomiasis compound that can be further optimized for its performance as an anti-trypanosomiasis drug by means of a computer-aided drug design (CADD) approach .
loading...
    loading...
Cat. No.: HY-128927
CAS No.: 2639874-49-8
Target:  

ADC Linkers

Research Areas:  

Cancer

Mc-Leu-Gly-Arg is a cleavable ether linker for antibody-drug conjugates (ADC) design.
loading...
    loading...
Cat. No.: HY-129352
CAS No.: 159857-90-6
Target:  

ADC Linkers

Research Areas:  

Cancer

Cbz-Phe-(Alloc)Lys-PAB-PNP is an cleavable linker for antibody-drug conjugates (ADC) design.
loading...
    loading...
Cat. No.: HY-150242A
Purity:  99.54%
Target:  

Liposome

Research Areas:  

Others

Cbz-Ala-Ala-Asn TFA is a peptide that designed based on the sequence of the substrate of legumain. Legumain is a cysteine protease. Cbz-Ala-Ala-Asn TFA can be applied as a scaffold for drug delivery .
loading...
    loading...
Cat. No.: HY-167706
CAS No.: 53882-13-6
Target:  

GPR35

Research Areas:  

Inflammation/Immunology

Diethyl-Lodoxamide is a highly potent GPR35 agonist with potential to inhibit inflammatory bowel disease. Diethyl-Lodoxamide activates GPR35 in humans, mice and rats, showing similar EC50 values. Diethyl-Lodoxamide can alleviate the clinical symptoms of DSS-induced inflammatory bowel disease in mouse models, and the effect is better than the traditional drug 5-ASA. The pharmaceutical properties of Diethyl-Lodoxamide have been optimized to better meet the requirements of drug design .
loading...
    loading...